Consort Medical's Bespak inks new agreement

Bespak manufactures drug delivery devices for pharmaceutical partner companies including respiratory, nasal, and injectable products, as well as devices for the point of care diagnostics market.

Under the agreement, Bespak will develop a Syrina embodiment of a single product through to commercialisation. Syrina is one of a range of drug delivery solutions developed by the company.

Through the use of a liquid gas propellant, rather than a spring to drive the delivery of the drug, Syrina facilitates delivery of a broader range of drug formulations and volumes, whilst also reducing or eliminating potential for glass syringe breakage.

The agreement also allows for inclusion of additional development programmes for other products.

Chief executive Jon Glenn said: "We are delighted to initiate this collaboration for the development of a Syrina auto-injector product. This reinforces Bespak's position as a leading provider of drug delivery device solutions. We believe that Syrina and Vapoursoft™ offer significant opportunities for pharmaceutical and biopharmaceutical companies to develop patient-centric presentations of their drugs."

The share price went p 0.81% at 1,117p at 1238 BST on Friday.